Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 11/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.41 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4388576 | 0.93 | AGTR2 (0.48) | ACEMCL1KMT2AAGTR2NR1H2 | |
| SCHEMBL29548835 | 0.92 | CYP3A4 (0.46) | MCL1MEN1RAB9AKMT2AUSP30 | |
| SCHEMBL29548632 | 0.90 | BCHE (0.42) | USP30NR1H2 | |
| SCHEMBL29548707 | 0.86 | NR1H2 (0.42) | AGTR2NR1H2 | |
| SCHEMBL24538202 | 0.85 | MMP2 (0.47) | MCL1KMT2AAGTR2NR1H2HTRA1 | |
| SCHEMBL12166250 | 0.85 | MMP2 (0.47) | MCL1KMT2AAGTR2NR1H2HTRA1 | |
| SCHEMBL2824741 | 0.85 | MMP2 (0.47) | MCL1KMT2AAGTR2NR1H2HTRA1 | |
| SCHEMBL13841901 | 0.85 | MMP2 (0.47) | MCL1KMT2AAGTR2NR1H2HTRA1 | |
| SCHEMBL13548957 | 0.82 | CARM1 (0.47) | AGTR2USP30NR1H2 | |
| SCHEMBL8254788 | 0.82 | CARM1 (0.47) | AGTR2USP30NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022087630-A1 | INHIBITORS OF AMINO ACID TRANSPORT | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2022-04-28 | — | — | WO | disclosed |